chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Child presented to clinic 4 days after getting flu vaccine with hives 4 hours after vaccine was administered. Nurse practitioner gave child Zyrtec and Zantac and told to take until hives go away.
throat sore; Chills; headaches; fatigue or asthma; fatigue or asthma; cough; tiredness; weakness; This is a spontaneous report from a non-contactable healthcare professional (the patient). A 56-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number EL3246), via an unspecified route of administration in the left arm on 11Jan2021 (age at vaccination unknown) as a single dose for COVID-19 immunization. The patient's medical history included asthma. The patient had no known allergies. The patient did not have COVID prior to vaccination. The patient was not pregnant at the time of vaccination. The patient took unspecified concomitant medications. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number EH9899), intramuscular in the left arm on 21Dec2020 10:00 (age at vaccination unknown) as a single dose for COVID-19 immunization. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Jan2021, the patient experienced chills, headaches, fatigue or asthma, cough, tiredness, weakness, and throat sore. The patient was treated with antibiotics (unspecified). The clinical outcome of chills, headaches, fatigue or asthma, cough, tiredness, weakness, and throat sore was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.
Marked swelling to lt thigh - injection site, within 4 hours. Pt in pain and discomfort, redness. Pt was examined in office. Advised Benadryl, Ibuprofen. Re-evaluated.
This spontaneous report as received from a healthcare worker refers to a 1 year old patient of unknown gender. The patient's concurrent conditions and medical history were not reported. On 20-JUL-2015, the patient was vaccinated with an improperly stored dose of PROQUAD (Merck) (lot number K010211 and expiration date 17-JAN-2016, dose and route of administration were not provided). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
sick; temperature of 101 degrees; headache/frontal type of headache; This is a spontaneous report from a contactable nurse (patient). A 50-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EL3249 and expiration date unknown), intramuscular on 26Jan2021 at 10:20 at a single dose for COVID-19 immunization. There were no medical history and no concomitant medications. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), batch/lot number: EK9231, intramuscular injection in left upper arm on 05Jan2021 as COVID-19 immunization and only had arm pain/soreness. As a nurse, the patient has given tons of vaccines. On 26Jan2021, she was given her second dose of COVID-19 vaccine around 10:20 a.m. She didn't hurt right away, it started later on. By 6pm, she got home, so sick and had a temperature of 101 degrees. She didn't go to work as she has been running a temperature and she has taken Tylenol. She knows the vaccine works the same, but everybody acts different. The patient also asked if a high temperature of 101 degrees a common side effect and if it is a normal reaction and how long it typically last. The patient states she has never been so sick like this in her life. The patient never gets sick and wanted to know if this is a common thing. She hasn't called her primary doctor. She took Tylenol Extra Strength, 6 or 7pm, also in the middle of the night and then again at 9am the following morning. Her fever has gone down a little bit, but the headache was so bad. It's like a frontal type of headache and it hurts so bad. The headache also began around 6pm yesterday and has converted into fever. The patient wanted to know if it is common to have this type of reaction. The patient is getting so tired and declined to continue with the report, stating she just wants to lay down. The event temperature of 101 degrees was resolving while the outcome of the rest of the events was unknown.   No follow-up attempts are possible. No further information is expected.
Swollen lymph nodes under left arm pit.  Very noticeable when raising arm.  Look like sunken baseball in my arm pit.
Fatigue and slight fever lasting 72 hours first onset 24 hours after injection. Swollen lymph node under right collar bone starting 24 hours after injection and lasting 72 hours.
significant increases in mental health symptoms of depression and anxiety for several days that was included suicidal thoughts; significant increases in mental health symptoms of depression and anxiety for several days that was included suicidal thoughts; This spontaneous case was reported by a patient and describes the occurrence of DEPRESSION (significant increases in mental health symptoms of depression and anxiety for several days that was included suicidal thoughts) and ANXIETY (significant increases in mental health symptoms of depression and anxiety for several days that was included suicidal thoughts) in a 38-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     Concurrent medical conditions included Anxiety and Depression.    On 14-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 14-Oct-2023, the patient experienced DEPRESSION (significant increases in mental health symptoms of depression and anxiety for several days that was included suicidal thoughts) and ANXIETY (significant increases in mental health symptoms of depression and anxiety for several days that was included suicidal thoughts). At the time of the report, DEPRESSION (significant increases in mental health symptoms of depression and anxiety for several days that was included suicidal thoughts) and ANXIETY (significant increases in mental health symptoms of depression and anxiety for several days that was included suicidal thoughts) was resolving.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.       No concomitant medications were reported.  Significant increases in mental health symptoms of depression and anxiety for several days that was included suicidal thoughts. It is unknown if the patient experienced any additional symptoms/events. The patient did not have any additional medical history, concomitant disease or risk factor. There were no lab data/results available.   No treatment medications were provided.
On 10/01/01, the child received her 4th injection of Infanrix. On that date, she also received her 4th injections of Prevnar and Hib-Titer. On 10/3/01, 2 days post vax, the infant developed a fever of 103F which was treated with Tylenol. Approx. 5 hours, post vax, the child "experienced a seizure episode described as jerking of extremities, eyes rolling back and lips blue, that lasted for 10 to 15 minutes". Tylenol was administered to the child and she was taken to the clinic. At the clinic, her temperature was 102.7F, rectally. Dx of febrile seizure and pharyngitis were made. "On the same day, she experienced a 2nd episode of seizure similar in description to the earlier seizure that lasted 8 minutes". At that time, the child's temperature was 106F, rectally. The child was hospitalized. The child recovered fully and was discharged from the hospital after 2 days. The investigator reportedly considered the febrile seizure and pharyngitis to be "possibly related" to Prevnar administration; relationship to the other vaccines was not reported.
Low grade fever, pain at the injection site, severe chills, severe muscle and body aches, severe fatigue and tiredness, severe nasal congestion, severe runny nose, unable to perform normal daily activities for 3 days, continued with residual symptoms and mild to moderate activity impairment for 9 days.
36hr p/vax scattered vesicular lesions w/erythematous base;15 lesions on scalp, trunk, lower extremities;lt pos auricular lymphadenopathy;pt dx w/chickenpox;
Nausea all night long; headache; feels weak; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea all night long), HEADACHE (headache) and FATIGUE (feels weak) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 ml. On 25-Feb-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On 25-Feb-2021, the patient experienced NAUSEA (Nausea all night long), HEADACHE (headache) and FATIGUE (feels weak). At the time of the report, NAUSEA (Nausea all night long), HEADACHE (headache) and FATIGUE (feels weak) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-027674 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-027674:FU completed on both crosslinked cases
Extreme cramping and belly discomfort in addition 4 bilious vomits and emergency treatment and admittance for intussusception on 9/15/2014. Second emergency room visit 10/02/2014 for viral gastroenteritis.
Patient presented to clinic for COVID-19 immunization. Patient previously received 3 doses of Pfizer COVID-19 vaccine. Patient presented for Bivalent booster. RN administered Pfizer 12+ primary series, not Bivalent formulation. Vaccine administered at 0915 today, contacted patient at 1004. Informed patient of situation. Patient denies currently experiencing any symptoms. Informed patient of possibility to receive Bivalent booster in 2 months per CDC guidelines. Patient verbalized understanding and willingness to receive Bivalent dose. Patient stated no further questions.
pt recvd vax & 2 days later exp stomach pain & nausea; exp the same sx 1 wk later which time was hospitalized for 1 day; dx abdo cramps & nausea; 3 wks later these sx reoccurred;
The vial had been punctured on 01Sep2021 and out for 24-36 hours at room temperature.; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (The vial had been punctured on 01Sep2021 and out for 24-36 hours at room temperature.) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     The patient's past medical history included Liver transplantation on 30-Jul-2012. Concurrent medical conditions included Drug allergy (Allergic to Tramodol), Chronic kidney disease since 02-Feb-2015 and Hypertension since 11-Jan-2017. Concomitant products included TACROLIMUS (PROGRAF) from 30-Jul-2012 to an unknown date for Chronic kidney disease, AMLODIPINE from 04-Jun-2018 to an unknown date and CARVEDILOL (COREG) from 15-Dec-2020 to an unknown date for Hypertension, ZOLPIDEM TARTRATE (AMBIEN) from 29-Sep-2016 to an unknown date for Insomnia.    On 02-Sep-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Sep-2021, the patient experienced PRODUCT STORAGE ERROR (The vial had been punctured on 01Sep2021 and out for 24-36 hours at room temperature.). On 02-Sep-2021, PRODUCT STORAGE ERROR (The vial had been punctured on 01Sep2021 and out for 24-36 hours at room temperature.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The treatment information was not provided. The race of the patient was reported as black. The reporter reported that the vial was opened on 01-SEP-2021 and was administered on 02-SEP-2021 .The vial was out at room temperature for about 24-36 hours. There was no temperature excursion reported. One dose was administered to the patient and remaining six doses were not administered to any patient.   Most recent FOLLOW-UP information incorporated above includes: On 07-Sep-2021: Follow-up information received Include Patient Race, Ethnicity, medical history and concomitant medication.
I received my first dose 05/25/2021. On my vaccination card, the administered nurse wrote for me to come back 06/15/2021 for my second dose. So I did today and got it done. Within few minutes of getting it administered, I developed a rash on my left arm (injection site), my heart began to beat rapidly, & I was experiencing shortness of breathe. They asked me to stay an additional 15-30 minutes and so I did until I felt a little better to leave.  I called my sister, considering we received our first dose on the same day but different place and she questioned why I got mines early and I explained that?s what my card said.  We hung up and I did some additional research, went on the CDC website and saw I was to get my second dose 28 days from my first dose and today made 21 days!   Same administrator the first time gave me my second dose today. She failed to correctly time my dose and didn?t not double check it was correct.  I never knew about the timing until today and as a healthcare professional, she should have known considering she would have been properly trained and now I?m experiencing difficulty breathing, chest pains, & heart beat feels off!
Is it possible to get a sore throat from it.; This case was reported by a consumer via interactive digital media and described the occurrence of sore throat in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on unknown date).   On 28th July 2020, the patient received the 2nd dose of Shingrix. In July 2020, less than a week after receiving Shingrix, the patient experienced sore throat. On an unknown date, the outcome of the sore throat was unknown.   It was unknown if the reporter considered the sore throat to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication.  The patient received Shingrix and asked whether it was possible to develop a sore throat from it. No other information was reported.
Shortness of breath, cough, felt like a sinus infection. I had a nasal drip.
diverticulitis; Dizziness; nausea; general unwell; affected my sense of taste; After losing part of her sense of smell since Mar2020, it came back really strong; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm right on 31Mar2021 16:00 (Batch/Lot Number: ER8734) as single dose for covid-19 immunisation. Medical history included diverticulitis, abscess in back at the moment of the vaccination, and losing part of her sense of smell from Mar2020. There were no concomitant medications, and vaccines in four weeks. The patient experienced dizziness, nausea and generally unwell. Two days after receiving the vaccine, on 02Apr2021 15:00, patient was in the ER with diverticulitis. She had to take Ciprofloxacin and metronidazole. After losing part of her sense of smell since Mar2020, it came back really strong. It affected her sense of taste and all food taste bad now. It was like pregnancy sickness. Her sense of smell came in an estrange manner. The events were experienced on 02Apr2021 15:00. Outcome of the events was not recovered. Patient was not diagnosed with covid prior to vaccination and had not been tested post vaccination.
15APR96 pt recv vax & 6min later RN noted purple pea to dime size spots (no blanching w/spots) on infants face;about 15min p/inj lung sound clear but pt seemed to stare off, unblinking;mom described pt as feeling heavy;unresponsive;
Info has been received from a physician concerning a female pt with no allergies or medical history, who on 10/21/98, was vaccinated with a third dose of MMRII. Concomitant therapy included prenatal vitamins (unspecified). On approximately 4/28/06, the pt was seen by the physician due to her neck area being swollen. She had no fever or sore throat. Just swelling. She was unable to eat or drink and was hospitalized on 3/28/06. She had antibody liters drawn before admission to the hospital. A rubeola titer was less than 0.9, a mumps titer was less than 0.8, and a rubella titer was less than 0.8. At the time of the report, the pt was recovering. A product complaint was not involved. At the time of the report, the pt was 34 years old and pregnant at 30 weeks gestation. Swollen neck area, unable to eat or drink, rubeola titer less than 0.9, mumps titer less than 0.8, and rubella titer less than 0.8, were considered to be other important medical events by the reporter. Additional info has been requested.
Felt very tired and fatigued  shortly after being vaccinated.   Went home to bed the whole weekend.  On Monday felt chills, fatigue, malaise and loss of appetite.  On Wednesday 4/14/2021 I felt very ill so I went to emergency room.   They did various tests and chest X-ray and diagnosed me with a pneumonia.  Later that day they diagnosed me with COVID when my test results came back positive.
Mom took child to ER 8/10/03 with complaint of redness to left inner thigh since vaccine administered on 8/8/03. No treatment was indicated. Seen here on 8/11/03. Again, no treatment necessary-mild erythema to left leg.
Deltoid soreness/tenderness x 3 wks. Muscle felt rigid. Afebrile.
Given DTaP/ IPV on 8/1/03-next a.m. mom noticed Lt arm swollen red tender to touch from shoulder to elbow. No temp.
The pt has a small knot and redness at the Dtap vaccine site. Some warmth also was experienced. Advised warm clothes and Ibuprofen.
This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Pfizer product on 03/09/2021, 03/30/2021, and 10/26/2021. The individual also received a dose of the Moderna product on 06/24/2022. They tested positive for COVID-19 on 07/30/2022 at the nursing home at which they were a resident. They were described as having developed "weakness" as a result of the COVID-19 infection. They fell on 07/31/2022 and died in the ambulance on the way to the hospital. This individual was not admitted to hospital for this illness.
Received MMR, Hib, Varicella on 6/6/07. That evening got sleepy, fever 103.7 Right and vomiting on 6/7/07 got needle point red rash on body and vomiting and fever 105.8-all day. Gave Tylenol X2 on that day=slept all day or screamed. Fever gone Sunday. Has been sleeping or crying since. sleeping 19 hrs/day, eating poorly. Seizure type activity 6/7/07.
2/1/2021, on the 6th day from the time of the vaccination, at approximately 7:00 I began having a severe headache and my heart rate was on and off irregular.  I could only sleep partial sitting to keep heart in regular.  2/2/2021: Next morning, okay but tired, but went to work. work at desk with computer.  That evening, I began having severe breakouts like hives -hot, burning, itching, swelling.  Started under the breast with a large red circle and then on lower stomach, lower back.  Next day, 2/3/2021. breakout under breast still evident red and painful; breakout moved to other parts of body now breakouts are on inside of thigh and lower leg. Continue with Benadryl. Helps with itching but does not stop the breakouts. 2/4/2021: - Continue with breakouts.  Some get better, go away but some continue.  That night began swelling in roof of mouth, hot and painful and right side of throat (inside).  Went to Emergency room Doctor said continue with Benadryl and see primary doctor.  2/5/2021: - Breakouts continue but changes somewhat.  Now affecting joints.  Hot, red, swelling, itching palm of hands, some finger joints and back of hands.  Bottom of feet & sides, and ankles.  Side of knees, elbows.    Continue with Benadryl.  Helps some with anti-itch cream. 2/6/2021 + - Continue with breakouts.  Rash on arm where vaccine shot was administered. Breakout Rash and swelling under arm both arms and other parts of body.  2/16/2021? Appoint with Cardiologist, Dr.  Begin medication for irregular heart rate.  Metoprolol Tartrate 25 mg. 1 x day. Continue with breakouts. 3/4/2021: Appoint with allergy specialist, Dr., Allergy. She prescribed Cetirizine 10 mg 2 x day, Famotidine 20 mg 2 x day.  Begin medications. Very helpful swelling went down in hands and feet.  Breakouts stopped. 3/6/2021: Breakouts start again but very small areas; 3/9/2021? hot itching, knotty areas on buttocks, inside of knee.  As of 3/19/2021 (date of this report) Continue to have painful breakouts in various places? Intense varies. Return to allergy specialist 4/1/2021 for appointment.
Received Pfizer COVID-19 vaccines at 18 and 21 weeks pregnant. While in labor in triage at 40 weeks pregnant, frequent PVCs were detected on the monitor. No known prior history of PVCs. Follow up with a cardiologist for an EKG and holter monitor test showed a PVC burden of 20%. Her PVCs are benign, not causing any dizziness, blood pressure issues, or other symptoms. Unlikely to be related to vaccination but reporting here in case a pattern emerges with other people. The patient was also ill with COVID-19 in December 2020, several months before vaccination.
Jaundice and dark urine was noted on May 22,2021, went to the doctors and had blood work and a CAT scan done. I had liver enzymes as high as 600-700, CAT scan showed edema of the portal valve and a slightly enlarged liver.  I also was diagnosed with Hemolytic Anemia. I never had any symptoms in my life like these, no family history either.  My blood work now shows that everything is going back to normal with no treatment at all.
12/29/2020 - Moderna COVID 19 Vaccine #1 administered 1/7/2021 - Right ear pain, worsening over 7 days and not responsive to antibiotics 1/14/2021 - Right facial palsy; negative brain MRI w/w/o 1/21/2021 - Diagnosis of Ramsay Hunt syndrome by neurology
shingles/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 month after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 08-Jan-2023 Reporter's comment: This case was reported by a patient via interactive digital media. The patient did not experienced chickenpox. The patient received the Shingles vaccine and 1 month later the patient got shingles. The patient was asking someone to explain. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule and laboratory confirmation of shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Patient developed a headache over the frontal region, above left eye and back of head at 4 PM following the vaccination.  The headache was followed by nausea and fatigue the following morning and left her in bed through Saturday (day 3 following vaccination).  She was seen by ER on Saturday morning and was given lorazepam, ondansetron, scopolamine and IV fluids.  She was diagnosed with vertigo and the scopolamine continued in place through Tuesday.  Symptoms resolved following the Emergency Room visit and she remains asymptomatic today (21 days later).